Patents by Inventor David Clapham

David Clapham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170164591
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 15, 2017
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Publication number: 20170107269
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: August 19, 2016
    Publication date: April 20, 2017
    Inventors: David CLAPHAM, Dejian REN
  • Patent number: 9618521
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: April 11, 2017
    Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
  • Publication number: 20160353720
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Applicants: Children's Medical Center Corporation, Children's Medical Center Corporation
    Inventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
  • Publication number: 20160353721
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: August 19, 2016
    Publication date: December 8, 2016
    Inventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
  • Patent number: 9125352
    Abstract: A method for the culture of somatic plant embryos comprising contacting said embryos with a culture medium containing a plasmolytic or near plasmolytic concentration of a sugar alcohol or a combination of sugar alcohols; and culturing said embryos in said culture medium for a time period suitable for the desired level of maturation to be achieved. Inositol is a preferable sugar alcohol.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: September 8, 2015
    Assignee: SweTree Technologies AB
    Inventors: Ulrika Egertsdotter, David Clapham
  • Publication number: 20150219626
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: September 5, 2014
    Publication date: August 6, 2015
    Inventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
  • Publication number: 20150219629
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Application
    Filed: September 2, 2014
    Publication date: August 6, 2015
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: David CLAPHAM, Dejian REN
  • Publication number: 20150212069
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: August 13, 2014
    Publication date: July 30, 2015
    Inventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
  • Patent number: 9068018
    Abstract: Nucleic acid and protein sequences relating to a proton channel (Hv1) are disclosed. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the Hv1 gene and protein are disclosed. Also provided are methods of identifying modulators of Hv1 activity, methods of geno typing subjects with respect to Hv1, and methods of diagnosing and treating Hv1-mediated disorders.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: June 30, 2015
    Assignee: Children's Medical Center Corporation
    Inventors: Ian S. Ramsey, Magdalene M. Moran, Jayhong A. Chong, David Clapham
  • Publication number: 20140363813
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Application
    Filed: April 10, 2014
    Publication date: December 11, 2014
    Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
  • Patent number: 8859197
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: October 14, 2014
    Assignee: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian S. Ramsey, David Clapham
  • Patent number: 8852860
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: October 7, 2014
    Assignee: Children's Medical Center Corporation
    Inventors: David Clapham, Dejian Ren
  • Patent number: 8835105
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: September 16, 2014
    Assignee: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian S. Ramsey, David Clapham
  • Patent number: 8729248
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: May 20, 2014
    Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas System
    Inventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
  • Publication number: 20130065306
    Abstract: A method for the culture of somatic plant embryos comprising contacting said embryos with a culture medium containing a plasmolytic or near plasmolytic concentration of a sugar alcohol or a combination of sugar alcohols; and culturing said embryos in said culture medium for a time period suitable for the desired level of maturation to be achieved. Inositol is a preferable sugar alcohol.
    Type: Application
    Filed: March 29, 2011
    Publication date: March 14, 2013
    Inventors: Ulrika Egertsdotter, David Clapham
  • Publication number: 20120270236
    Abstract: Nucleic acid and protein sequences relating to a proton channel (HvI) are disclosed. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the HvI gene and protein are disclosed. Also provided are methods of identifying modulators of HvI activity, methods of geno typing subjects with respect to HvI, and methods of diagnosing and treating HvI-mediated disorders.
    Type: Application
    Filed: February 15, 2007
    Publication date: October 25, 2012
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Ian S. Ramsey, Magdalene M. Moran, Jayhong A. Chong, David Clapham
  • Patent number: 8137918
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: March 20, 2012
    Assignee: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian S. Ramsey, David Clapham
  • Patent number: 8093242
    Abstract: The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I) in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: January 10, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Clare Louise Anderton, Ronnie Maxwell Lawrence, David Clapham
  • Publication number: 20110136798
    Abstract: The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I) in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
    Type: Application
    Filed: August 4, 2009
    Publication date: June 9, 2011
    Inventors: Clare Louise Anderton, Ronnie Maxwell Lawrence, David Clapham